Fertility Testing Is Big Business—But Is It Really Helping You Get Pregnant?
By Elissa Strauss,
Glamour Magazine [cites CGS' Fellow Gina Maranto]
| 12. 28. 2017
New evidence shows that the tests many companies use to determine a woman's chances of having a baby are based on bogus science.
"Learn how many high quality eggs you have remaining and your chances of getting pregnant now and in the future,” beckons Egg-Q, one of the handful of new startups offering fertility testing to women concerned about their reproductive potential. The desire to know “how long you have left to conceive,” as offered by LetsGetChecked, or, more simply, “powerful information about your fertility,” courtesy of Modern Fertility, is understandable. Women are having children later than ever, a shift that has proved professionally and personally beneficial, but reproductively challenging. When offered a fertility magic eight ball, many can’t help but take a peek, hoping to discover something, anything, about their baby-making future.
If only that was possible.
These fertility blood tests provide women with an assortment of figures and graphs charting their ovarian reserve, along with a few other measures that will present themselves as authoritative, fate-determining even. But in reality, they offer little more than...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...